COVID vaccines began to show promise just months after the novel coronavirus started spreading across the globe.
So why have decades of HIV/AIDS research yielded so little progress on a jab to prevent a disease that claimed some 680,000 lives in 2020?
As the globe marks World AIDS Day on Wednesday, why is there still no vaccine to protect people from the Human Immunodeficiency Virus (HIV)?
One answer is that the political will and colossal investment that have spurred on Covid vaccine development have largely been missing from AIDS vaccine research since HIV was discovered in 1983.
But another lies in the complexity of the science behind HIV.
"With COVID vaccines, researchers worry about the vaccine being able to fend off a handful of variants that have become particularly worrisome," reads a June report by the International AIDS Vaccine Initiative (IAVI).
"But for HIV, there are millions and millions of different viruses that have resulted from the virus's stealth ability to rapidly mutate... It is this astonishing level of diversity that any HIV vaccine must contend with."
Olivier Schwartz, head of the viruses and immunity unit at the Pasteur Institute in Paris, says that while most people can recover naturally from an initial coronavirus infection and thus acquire immunity, this is not the case for HIV.
"HIV mutates much more easily than Covid and so it is more difficult to generate so-called broadly neutralising antibodies that could prevent infection," he said.
Only a handful of people naturally produce these antibodies when exposed to HIV.
Research into a vaccine has meant studying those rare responses, understanding how they work, and trying to replicate them in healthy people's immune systems.
- An mRNA jab? -
Several dozen vaccines are being studied, with one by US firm Moderna seeking to use the same mRNA delivery method as its popular Covid vaccine.
The June report describing the research explains how the mRNA jab is meant to deliver instructions for a process called "germline targeting".
This means "guiding the immune system, step by step, to induce antibodies that can counteract HIV", the report explains.
So far, the technique is complex, involving an initial shot to activate important B-cells before several jabs attempt to spur the body into producing a range of antibodies.
Being able to visualise a way forward has given researchers hope, and some say it's thanks in no small part to the pandemic.
"These last few years have seen unprecedented growth in our understanding of the immune system," Serawit Bruck-Landais of French AIDS organisation Sidaction told AFP.
But even with seeming breakthroughs, Bruck-Landais says, progress on an HIV jab is "not enough to be able to say we will have an AIDS vaccine soon".
The US clinical trials for the Moderna vaccine that were set to begin in August are still listed on the National Institutes of Health website as "not recruiting".
- 'Lack of investment' -
Researchers looking into vaccines say they are overlooked in terms of funding.
"The market is too weak for pharmaceutical groups and there's a disappointing lack of investment," says Nicolas Manel, a research director at the French National Institute of Health and Medical Research (INSERM).
"Many researchers are very motivated, but they have to make do with the funds they have."
In the absence of a vaccine, focus has historically been on promoting preventative measures like protected sex, clean needles, and overall better access to healthcare for marginalised populations.
Some 38 million people across the globe live with the virus.
Monsef Benkirane, research director at the France-based Institute of Human Genetics, points to important improvements in medicine that allow many people with HIV to live longer, healthier lives.
Importantly, by reducing an infected person's viral load, HIV treatments today can vastly decrease or eliminate a person's chances of transmitting HIV to another person.
But Benkirane says many people lack access to the treatments, while those who do have access sometimes struggle to follow through and take all the necessary medications.
"In addition to improving access to treatments, there are still problems with people actually sticking to the treatment regimens, even in Europe," he said.
ETX Studio
Thu Dec 02 2021
As the globe marks World AIDS Day on Wednesday, why is there still no vaccine to protect people from the Human Immunodeficiency Virus (HIV)? - ETX Studio
King Charles and Queen Camilla visit Canberra on Australia tour
This is King Charles' first major foreign trip since being diagnosed with cancer in February.
Indonesia's Prabowo plans military academy retreat for new cabinet
The retreat is aimed at forming a bond between around 100 cabinet ministers and their deputies, according to migrant protection minister.
Four loan sharks held for alleged involvement in paint splashing, arson in six states
The syndicate is believed to have conducted illegal money-lending activities, involving loan sharks and online money-lending, police said.
China's PCT international patent applications top world for 5 consecutive years: WIPO chief
China has become the country with the most international patent applications, according to AIPPI President Shoichi Okuyama.
Charles Leclerc wins US Grand Prix; Max Verstappen 3rd after Norris penalty
Charles Leclerc also won the Monaco Grand Prix and Italian Grand Prix this year and sits third in the driver standings.
Australia's Qantas told to pay $114,000 to 3 sacked workers in landmark outsourcing case
Qantas claims the sackings were warranted as a cost-cutting measure during the COVID-19 pandemic.
After Sinwar's death, Israel aims to lock in strategic gains before US election
Israeli leaders are seeking to reshape regional landscape in Israel's favour and shield its borders from any future attacks, sources said.
Netanyahu told Trump Israel will make decisions based on its interests, PM's office says
Israel is pondering its military reaction to recent Iranian missile strikes.
Ringgit extends positive momentum to open higher against US dollar
The ringgit traded higher against the US Dollar in today's early session, driven by continued buying interest towards the local currency.
BHP faces $47 billion UK lawsuit over Brazilian dam collapse
More than 600,000 Brazilians, 46 local governments, and around 2,000 businesses are suing BHP over the collapse of the dam.
Trump hands out french fries in Pennsylvania, Harris visits Georgia churches
Both candidates were scrambling for votes in the most competitive states.
Brazil's Lula cancels BRICS trip after minor brain hemorrhage from fall
Lula "was advised to avoid long-distance air travel but is otherwise able to carry out his regular duties."
Lebanese flee as blasts hit Beirut, Israel warns of strikes on Hezbollah finance arm
On Sunday Israel said it hit Hezbollah's intelligence headquarters and an underground weapons workshop in Beirut.
87 people killed or missing in northern Gaza's Beit Lahiya, health ministry says
A total of 87 people were killed or missing under the rubble after an Israeli attack on Saturday on northern Gaza's town of Beit Lahiya.
Hundreds of colonists storm Al-Aqsa Mosque under heavy Israeli protection
Hundreds of Israeli colonists stormed the Al-Aqsa Mosque compound on Sunday morning during the fourth day of the Jewish Sukkot festival.
ANALYSIS - What could happen if Trump rejects the US election results
If Trump seems to be losing, the delay could let him claim fraud and undermine confidence in election officials.
Motorcycling - Marquez wins Australian MotoGP after intense battle with Martin
The 31-year-old, third in the championship standings, has now won the Australian MotoGP four times in the premier class.
Prabowo takes up Indonesian presidency, vows to tackle corruption, other issues
Indonesia's Prabowo Subianto on Sunday took over as president of the world's third-largest democracy, vowing to combat internal issues
Nepal's Sherpas deserve more, says teenager who scaled world's 14 tallest peaks
Sherpas are known for climbing skills that make them the backbone of mountain expeditions.
Inside the underground lab in China tasked with solving a physics mystery
China will soon collect neutrino data, aiming to unravel one of particle physics' biggest mysteries.